TrialInvestigational new drugs2012

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Simon Pacey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.